Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414992105> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2414992105 endingPage "6" @default.
- W2414992105 startingPage "911" @default.
- W2414992105 abstract "To evaluate the efficacy and safety of indinavir/ritonavir 400/100 mg plus stavudine and lamivudine twice daily in antiretroviral-therapy-naive Thai HIV-1-infected patients.This was an open-label, non-randomized single arm study. Antiretroviral-naive patients (n=80) with CD4+ cell count < 200 x 10(6)/l were started on stavudine and lamivudine plus indinavir/ritonavir 400/100 mg twice daily. CD4+ cell count and HIV RNA were determined at week 0, 12, 24, 48 and 96. HIV RNA was measured to a level of 50 copies/ml by RT-PCR assay. Primary analysis was statistically performed as intent to treat. The primary endpoint was the percentage of patients with plasma HIV RNA below 50 copies/ml at week 96.Eighty antiretroviral-therapy-naive patients with median CD4+ cell count 19 x 10(6)/l (range: 2 - 197 x 10(6)/l) and median baseline plasma HIV RNA of 174,000 copies/ml (range 16,800-750,000 copies/ml) were enrolled. In the intent-to-treat analysis at week 96, the proportion of patients with HIV RNA of <50 copies/ml was 68.8% (95% confidence interval [CI]: 68.3-69.3), whereas it was 88.7% (95% CI: 88.1-89.3) in the on-treatment analysis at week 96. The regimen was well tolerated. Hyperglycaemia, hypercholesterolaemia and hypertriglyceridaemia were found in 8.3, 33.3 and 37.0% of the patients, respectively. Treatment was stopped in 18 patients; two from intolerance, two switched therapy, four as a result of serious adverse event-related death, and ten were lost to follow-up.Our study demonstrates that indinavir/ritonavir 400/100 mg plus stavudine and lamivudine twice daily, the least expensive boosted protease inhibitor, appears to be effective and safe up to 96 weeks despite high baseline viraemia and low CD4+ cell count in antiretroviral-naive patients." @default.
- W2414992105 created "2016-06-24" @default.
- W2414992105 creator A5042629578 @default.
- W2414992105 creator A5051844566 @default.
- W2414992105 creator A5067547071 @default.
- W2414992105 creator A5070410197 @default.
- W2414992105 date "2005-01-01" @default.
- W2414992105 modified "2023-09-23" @default.
- W2414992105 title "Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes." @default.
- W2414992105 cites W2004293828 @default.
- W2414992105 cites W2008565853 @default.
- W2414992105 cites W2030127456 @default.
- W2414992105 cites W2043390279 @default.
- W2414992105 cites W2044066378 @default.
- W2414992105 cites W2090031141 @default.
- W2414992105 cites W2102530919 @default.
- W2414992105 cites W2116673770 @default.
- W2414992105 cites W2117099115 @default.
- W2414992105 cites W2127961073 @default.
- W2414992105 cites W2157623629 @default.
- W2414992105 cites W2164349191 @default.
- W2414992105 cites W2317784465 @default.
- W2414992105 cites W2318289184 @default.
- W2414992105 cites W2319472437 @default.
- W2414992105 cites W2331916023 @default.
- W2414992105 cites W4250637862 @default.
- W2414992105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16430196" @default.
- W2414992105 hasPublicationYear "2005" @default.
- W2414992105 type Work @default.
- W2414992105 sameAs 2414992105 @default.
- W2414992105 citedByCount "5" @default.
- W2414992105 crossrefType "journal-article" @default.
- W2414992105 hasAuthorship W2414992105A5042629578 @default.
- W2414992105 hasAuthorship W2414992105A5051844566 @default.
- W2414992105 hasAuthorship W2414992105A5067547071 @default.
- W2414992105 hasAuthorship W2414992105A5070410197 @default.
- W2414992105 hasConcept C126322002 @default.
- W2414992105 hasConcept C142462285 @default.
- W2414992105 hasConcept C168563851 @default.
- W2414992105 hasConcept C203014093 @default.
- W2414992105 hasConcept C203092338 @default.
- W2414992105 hasConcept C2522874641 @default.
- W2414992105 hasConcept C2777210460 @default.
- W2414992105 hasConcept C2777447569 @default.
- W2414992105 hasConcept C2777869810 @default.
- W2414992105 hasConcept C2779298103 @default.
- W2414992105 hasConcept C2779889181 @default.
- W2414992105 hasConcept C2780593183 @default.
- W2414992105 hasConcept C2781413609 @default.
- W2414992105 hasConcept C2993143319 @default.
- W2414992105 hasConcept C3013748606 @default.
- W2414992105 hasConcept C44249647 @default.
- W2414992105 hasConcept C71924100 @default.
- W2414992105 hasConcept C90924648 @default.
- W2414992105 hasConceptScore W2414992105C126322002 @default.
- W2414992105 hasConceptScore W2414992105C142462285 @default.
- W2414992105 hasConceptScore W2414992105C168563851 @default.
- W2414992105 hasConceptScore W2414992105C203014093 @default.
- W2414992105 hasConceptScore W2414992105C203092338 @default.
- W2414992105 hasConceptScore W2414992105C2522874641 @default.
- W2414992105 hasConceptScore W2414992105C2777210460 @default.
- W2414992105 hasConceptScore W2414992105C2777447569 @default.
- W2414992105 hasConceptScore W2414992105C2777869810 @default.
- W2414992105 hasConceptScore W2414992105C2779298103 @default.
- W2414992105 hasConceptScore W2414992105C2779889181 @default.
- W2414992105 hasConceptScore W2414992105C2780593183 @default.
- W2414992105 hasConceptScore W2414992105C2781413609 @default.
- W2414992105 hasConceptScore W2414992105C2993143319 @default.
- W2414992105 hasConceptScore W2414992105C3013748606 @default.
- W2414992105 hasConceptScore W2414992105C44249647 @default.
- W2414992105 hasConceptScore W2414992105C71924100 @default.
- W2414992105 hasConceptScore W2414992105C90924648 @default.
- W2414992105 hasIssue "8" @default.
- W2414992105 hasLocation W24149921051 @default.
- W2414992105 hasOpenAccess W2414992105 @default.
- W2414992105 hasPrimaryLocation W24149921051 @default.
- W2414992105 hasRelatedWork W2025587112 @default.
- W2414992105 hasRelatedWork W2066184048 @default.
- W2414992105 hasRelatedWork W2108130455 @default.
- W2414992105 hasRelatedWork W2159943759 @default.
- W2414992105 hasRelatedWork W2162114586 @default.
- W2414992105 hasRelatedWork W2317995319 @default.
- W2414992105 hasRelatedWork W2414992105 @default.
- W2414992105 hasRelatedWork W3028205985 @default.
- W2414992105 hasRelatedWork W344783904 @default.
- W2414992105 hasRelatedWork W2301387450 @default.
- W2414992105 hasVolume "10" @default.
- W2414992105 isParatext "false" @default.
- W2414992105 isRetracted "false" @default.
- W2414992105 magId "2414992105" @default.
- W2414992105 workType "article" @default.